Back to companies

CJ Bioscience

311690KRKRX

CJ 바이오사이언스

Revenue
₩3.5bn
FY2024
Operating income
-₩34.2bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)